The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis

被引:0
|
作者
Radic, M. [1 ]
Kaliterna, D. Martinovic [1 ]
Ljutic, D. [1 ]
机构
[1] Clin Hosp Split, Dept Internal Med, Split, Croatia
关键词
systemic sclerosis; anti-topoisomerase I antibody; contracture;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background It is found that an antibody directed against DNA topoisomerase I (anti-topo I abs) is detected almost exclusively in systemic sclerosis (SSc). These antibodies are predictors of pulmonary fibrosis and peripheral vascular disease. Objective Metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints flexion contractures are assessed as markers of active SSc. The aim of this study was to find out is there any relationship between anti-topo I abs and MCP and PIP joints flexion contractures. Methods Twenty-eight patients with active disease who fulfilled the American College of Rheumatology criteria for SSc were included in this study. Twenty eight healthy control subjects were also investigated. Clinical and radiological assessments of the hands were carried out. The flexion ranges in the 8 finger joints by goniometric measurement were obtained. Anti-topo I abs with an enzyme linked immunosorbent assay (ELISA) were measured. Results MCP and PIP joints flexion contractures and the levels of anti-topo I abs were significantly higher in patients with systemic sclerosis than in healthy control. The anti-topo I abs were found in 16 of 28 patients with systemic sclerosis. Sixteen of 28 patients with active disease had MPC and proximal PIP joints flexion contractures. In 16 SSc patients with anti-topo I abs, 13 had metacarpophalangeal and proximal interphalangeal joints flexion contractures. In only 3 patients of 16 with the flexion contractures the levels of anti-topo I abs were negative. The patients with MPC and PIP joints flexion contractures had higher mean value of anti-topo I abs titers (53.718 +/- 50.977 vs 8.127 +/- 8.915, P < 0.0001) than did those with no contractures. Furthermore, the titers of anti-topo isomerase I antibody positively correlated with the flexion contractures (r = 0.4252, P = 0.0241). Radiologically, joint space narrowing and flexion contractures of the fingers were seen significantly more frequently in the SSc patients with anti-topo I abs (P < 0.05). Conclusion Serum level of anti-topoisomerase I antibodies is in direct relationship with MPC and PIP joints flexion contractures.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [1] The level of anti-topoisomerase I antibodies correlates with the severity of metacarpophalaingeal and proximal nterphalangeal joints flexion contractures in patients with systemic sclerosis
    Radic, M.
    Kaliterna, D. Martinovic
    Ljutic, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 221 - 221
  • [2] The impact of sex and anti-topoisomerase I antibodies in systemic sclerosis
    De Angelis, Rossella
    LANCET RHEUMATOLOGY, 2022, 4 (10): : E651 - +
  • [3] Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis
    Boonstra, Maaike
    Bakker, Jaap A.
    Grummels, Annette
    Ninaber, Maarten K.
    Ajmone Marsan, Nina
    Wortel, Corrie M.
    Huizinga, Tom W. J.
    Jordan, Suzana
    Hoffman-Vold, Anna-Maria
    Distler, Oliver
    Toes, Rene E. M.
    Scherer, Hans Ulrich
    de Vries-Bouwstra, Jeska K.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (11) : 1897 - 1904
  • [4] Anti-topoisomerase I autoantibodies in systemic sclerosis
    Czoempoely, Tamas
    Simon, Diana
    Czirjak, Laszlo
    Peter Nemeth
    AUTOIMMUNITY REVIEWS, 2009, 8 (08) : 692 - 696
  • [5] Anti-Topoisomerase Antibodies Are Negatively Associated with Smoking in Systemic Sclerosis
    Wodkowski, Michael
    Hudson, Marie
    Proudman, Susanna
    Walker, Jennifer
    Stevens, Wendy
    Nikpour, Mandana
    Assassi, Shervin
    Mayes, Maureen
    Wang, Mianbo
    Baron, Murray
    Fritzler, Marvin
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 882 - 882
  • [6] Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies
    Liem, Sophie I. E.
    Neppelenbroek, Sam
    Fehres, Cynthia M.
    Wevers, Brigitte A.
    Toes, Rene E. M.
    Allaart, Cornelia F.
    Huizinga, Tom W. J.
    Scherer, Hans Ulrich
    De Vries-Bouwstra, Jeska K.
    RMD OPEN, 2023, 9 (01):
  • [7] SURVIVAL AND ORGAN INVOLVEMENT IN PATIENTS WITH LIMITED CUTANEOUS SYSTEMIC SCLEROSIS AND ANTI-TOPOISOMERASE ANTIBODIES
    Kranenburg, P.
    Van den Hombergh, W. M. T.
    Knaapen-Hans, H. K.
    van den Hoogen, F. H.
    Fransen, J.
    Vonk, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1126 - 1127
  • [8] Smoking and systemic sclerosis: influence on microangiopathy and expression of anti-topoisomerase I antibodies in a monocentric cohort
    Ciaffi, J.
    van Leeuwen, N. M.
    Huizinga, T. W. J.
    de Vries-Bouwstra, J. K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : S25 - S28
  • [9] Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
    Ochoa, E.
    Martin, J. -E.
    Assassi, S.
    Beretta, L.
    Carreira, P.
    Guillen, A.
    Simeon, C. P.
    Koumakis, E.
    Dieude, P.
    Allanore, Y.
    Garcia-Hernandez, F. J.
    Espinosa, G.
    Castellvi, I.
    Trapiella, J. L.
    Rodriguez, L.
    Gonzalez-Gay, M. A.
    Egurbide, M. V.
    Saez, L.
    Callejas-Rubio, J. L.
    Vargas-Hitos, J. A.
    Hunzelmann, N.
    Riemekasten, G.
    Witte, T.
    Distler, J. H. W.
    Kreuter, A.
    Lunardi, C.
    Santaniello, A.
    Tan, F. K.
    Shiels, P. G.
    Herrick, A.
    Worthington, J.
    Vonk, M. C.
    Koeleman, B. P.
    Radstake, T. R. D. J.
    Mayes, M. D.
    Martin, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : S31 - S35
  • [10] Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation
    Henes, Jorg
    Glaeser, Lennard
    Koetter, Ina
    Vogel, Wichard
    Kanz, Lothar
    Klein, Reinhild
    RHEUMATOLOGY, 2017, 56 (03) : 451 - 456